Biosenta Closes Private Placement Financing

Stock Information for BriaCell Therapeutics Corp.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About BriaCell Therapeutics Corp.

Biosenta to Field-Test Antimicrobial Nanoparticles with Livespace Homes in Alberta Multi-Unit Build
Former Canadian Coatings Association President & CEO Gary LeRoux joins Biosenta's Advisory Board
Veteran Finance Executive Tim Gillespie, CFA, Joins Biosenta as Strategic Advisor
Biosenta's Tri-Filler(TM) Nanoparticles Achieve 100% Killing of Pathogens at Industry-Low Dose in Peer-Reviewed Studies
Biosenta Inc. Achieves Major Breakthroughs in Bench Scale Production and Innovative Input Viability
Biosenta Inc. Announces Licensing Agreement with Lightweight Concrete Solutions
Biosenta Announces Private Placement Financing
Biosenta Announces Successful Launch of Bench Scale Production Plant and Exceeding Expectations of Tri-Filler(TM) Particle Encapsulation Technology

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.